MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$24,404K
(53.36%↑ Y/Y)
Other income, net
$17,914K
(1267.48%↑ Y/Y)
Interest income, net
$2,194K
(-43.19%↓ Y/Y)
Net loss
-$24,153K
(53.73%↑ Y/Y)
Net unrealized gain
on marketable...
-$251K
(-88.72%↓ Y/Y)
Total other income,
net
$20,108K
(288.79%↑ Y/Y)
Loss from operations
-$44,261K
(22.85%↑ Y/Y)
Revenue
$2K
(-71.43%↓ Y/Y)
Total operating
expenses
$44,263K
(-22.85%↓ Y/Y)
Other operating
income, net
$1,896K
(1493.28%↑ Y/Y)
Research and development
$36,604K
(-15.75%↓ Y/Y)
General and
administrative
$9,555K
(-31.97%↓ Y/Y)
Back